v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (85,015) $ (65,727)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 6,264 4,681
Stock-based compensation expense 42,686 36,761
Non-cash lease adjustment (477) (381)
Provision for credit losses 1,156 1,426
Inventory write-down 84 566
(Gain) loss on foreign currency transactions 353 (121)
Changes in operating assets and liabilities:    
Accounts receivable (22,923) (3,128)
Inventory (10,286) (10,500)
Prepaid expenses and other current assets 293 (671)
Other assets (3,472) (1,973)
Accounts payable 199 715
Accrued compensation 2,803 207
Accrued interest expense 152 94
Loan facility liability 0 (2,000)
Deferred revenue 2,602 1,352
Other liabilities (782) 41
Net cash used in operating activities (66,363) (38,658)
Cash flows from investing activities:    
Purchases of property and equipment (6,534) (7,506)
Net cash used in investing activities (6,534) (7,506)
Cash flows from financing activities:    
Proceeds from issuance of common stock from the exercise of stock options 504 3,249
Proceeds from the issuance of common stock under employee stock purchase plan 4,313 3,504
Net cash provided by financing activities 4,817 6,753
Effect of exchange rates on cash, cash equivalents and restricted cash (54) (33)
Net decrease in cash, cash equivalents and restricted cash (68,134) (39,444)
Beginning of the period 289,541 336,763
End of the period 221,407 297,319
Reconciliation of cash, cash equivalents and restricted cash to balance sheets:    
Cash and cash equivalents 218,369 294,281
Restricted cash 3,038 3,038
Cash, cash equivalents and restricted cash in balance sheets 221,407 297,319
Supplemental cash flow information    
Interest paid 2,393 2,632
Non-cash investing and financing activities    
Property and equipment included in accounts payable and accrued expenses $ 257 $ 714